As a counsel in the corporate/commercial team, Penny has extensive experience in the automotive, technology, life science, sport and retail sectors.
Penny combines her M&A experience with significant commercial experience and knowledge to advise on complex transformational projects, joint venture, cooperation and outsourcing projects, as well as strategic service and supply arrangements and governance structures.
Advising Novartis on US$16bn portfolio transformation transactions with GSK: acquiring oncology business; selling vaccines business; OTC joint venture; selling animal health business to Eli Lilly.
Advising Daimler AG in relation to its investment in, and ongoing commercial arrangements relating to, the Mercedes Team.
Advising the Kraft and Mondelez Groups on their demerger, as it affected their global coffee business.
Advising Johnson and Johnson on sale of Benecol brand; acquiring OTC brands of JB Chemicals and Pharmaceuticals Ltd across 12 CIS jurisdictions and Russian Federation.